Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CARLA: Etonogestrel Implant PK with LA Cabotegravir and Rilpivirine
NCT05156658Phase 4Withdrawn
- Start
- Jan 2024
- Primary completion
- Aug 2024
- Modality
- Orthosteric Ligands
01
Overview
Phase 4, open-label trial of etonogestrel in pregnancy. Planned start Jan 2024; status: withdrawn.
02
Drugs
etonogestrel
03
Conditions
pregnancy
Beyond the preview
Go deeper on NCT05156658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05156658.